The Key To Alexion's Long-Term Upside Potential, According To Credit Suisse
January 18, 2018 at 14:39 PM EST
Shares of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) have lost more than 10 percent over the past year, but one analyst is confident ...
